{
  "docId": "019de511-345d-7570-a494-480f2370811c",
  "docSlug": "ec9eb0ed92f9fb3cafb36e44028c44da",
  "documentTitle": "MaxCyte | IPO Presentation Deck | 34 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7843866,
  "pageNumber": 22,
  "pageCount": 34,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses a timeline-based process flow to map product usage and commercial terms across the development lifecycle.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-345d-7570-a494-480f2370811c/22",
  "deckHref": "/decks/019de511-345d-7570-a494-480f2370811c",
  "deckJsonHref": "/decks/019de511-345d-7570-a494-480f2370811c.json",
  "deckAnchorHref": "/decks/019de511-345d-7570-a494-480f2370811c#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.94,
        "x": 0.03,
        "y": 0.18
      },
      "kind": "diagram",
      "text": "Process timeline from Concept to On-Market",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0f23fd92-0643-4db1-84a3-3f676a12a19e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.85,
        "x": 0.08,
        "y": 0.28
      },
      "kind": "image",
      "text": "Instrument photos",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1268c393-84a7-4ba1-9f4a-dfbdba1540fb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.24,
        "x": 0.5,
        "y": 0.49
      },
      "kind": "list",
      "text": "cGMP Production in the Clinic: GTx used, SPL required, IP access, $250k annual license",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "720005bc-bd21-460d-8305-72159c9311fe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.24,
        "x": 0.24,
        "y": 0.49
      },
      "kind": "list",
      "text": "Optimization/Verification: ATx or GTx used, license options, no clinical rights, SPL required at IND",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "76d21753-d844-4161-9ae4-c652885faa48",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.2,
        "x": 0.76,
        "y": 0.49
      },
      "kind": "list",
      "text": "Approval/ On-Market: SPL required, sales-based payments, IP access, $250k annual license",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "845c93cd-8ac9-4065-991d-8df6e63402dd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.2,
        "x": 0.03,
        "y": 0.49
      },
      "kind": "list",
      "text": "Proof of Concept: No large scalability needed, ATx primarily used",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e9a94141-f233-496a-a1b5-21c7bd7fe422",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.94,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "A Single Delivery Platform for Cell Engineering from Concept to Clinic",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "27e67f2f-01ab-4198-9993-f8b5325aef7f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "107f4ec5-2712-44f2-a7c1-192b11463742",
      "evidence": "The slide maps a sequential process from concept to market.",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 23,
      "from": 21,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "74376caf-55e2-48ee-8219-1b80b07b8da2",
      "evidence": "Slides 21-23 discuss competitive analysis and the VLX platform.",
      "position": 1,
      "objective": "The consequences of not using MaxCyte's platform",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}